IQVIA Holdings Inc. (IQV Quick QuoteIQV ) today announced that it has collaborated with NRx Pharmaceuticals (NRXP Quick QuoteNRXP ) for pharmacovigilance services and medical information.
NRx Pharmaceuticals is a clinical-stage small-molecule pharmaceutical company involved in the development of therapeutics for the treatment of pulmonary diseases and central nervous system disorders. The company’s product, ZYESAMI, is an investigational pre-commercial drug for COVID-19-associated respiratory failure and is currently under phase III trials.
As part of the tie-up,....More>>>